atypical pneumonias: the basics nilesh patel, do october 8, 2008 st. joseph’s regional medical...
TRANSCRIPT
ATYPICAL PNEUMONIAS: THE BASICS
Nilesh Patel, DO
October 8, 2008
St. Joseph’s Regional Medical Center
QUESTIONS WE WILL ANSWER???
What is an atypical pneumonia? What are the organisms that compromise atypical
pneumonias? How do we test for atypical pneumonias; does it matter? What are the antibiotic choices? What should we think about when HIV patients present
with pneumonia?
OBJECTIVES We will discuss….
Mycoplasma pneumoniae Legionella sp. Chlamydia pneumoniae Chlamydia psittaci Viral pneumonias Pneumonia in the setting of HIV/AIDS--PCP
ATYPICAL PNEUMONIA: WHAT IS IT???
Infection of pulmonary parenchyma Community-acquired Classically—do not show up on Gram stain Characteristics
“Atypical” presentation/symptoms/diagnostics Insidious onset Nonproductive cough Constitutional symptoms Interstitial pattern on CXR Smoldering course
The lines are “blurred” Similar to typical organisms clinically and radiographically
ORGANISMS Mycoplasma pneumonia Viral pneumonias
RSV Parainfluenza Adenovirus Influenza Other
Chlamydia pneumonia Chlamydia psittaci Legionella pneumophila Coxiella burnetti (Q fever pneumonia) Francisella tularensis (Tularemia)
EPIDEMIOLOGY 4 million cases CAP/year
20-60% typical organisms
10-40% atypical organisms
Hard to quantify these organisms
PATHOPHYSIOLOGY
MYCOPLASMA PNEUMONIA Smallest free living organisms Prokaryotes No cell wall Most common cause of atypical pneumonia “Walking” pneumonia Community acquired Usually occur in young to middle aged patient Clinical symptoms
Insidious onset, protracted course Constitutional symptoms (fevers, chills, myalgias, body aches) Sore throat, HA Dry cough Chest pain/SOB
MYCOPLASMA: DIAGNOSTICS CXR
Consolidation Patchy infiltrates Interstitial pattern Pleural effusion
Labs WBC Cold agglutinin assays Other serum assays
Cultures Blood Sputum
MYCOPLASMA: TMT Macrolides
Azithromycin Erythromycin Clarithromycin
Doxycycline
LEGIONELLA Gram negative intracellular rods Fastidious Multiple serotypes Legionella pneumophila Community acquired Legionnaire’s disease Transmission from contaminated water sources Warm water environments No person to person transmission Outbreaks….Sporadic cases High mortality if not treated
LEGIONELLA Natural water habitats Water distribution systems Cooling towers Hot tubs/Spas Respiratory equipment Humidifiers Etc……
Travel Hotels Large Events Floods/Natural Disasters
LEGIONELLA: SYMPTOMS Incubation period: 2-10 days Clinical symptoms
Pulmonary Cough Chest pain Dyspnea
Extrap-pulmonary Constitutional symptoms GI symptoms—diarrhea, abd pain, n/v Neuro symptoms—HA, change in mental status
LEGIONELLA: DIAGNOSTICS CXR—variable
Consolidation Patchy infiltrates/Interstitial infiltrates Pleural effusions Multi-lobar
Labs CBC, SMA-7 (Hyponatremia, Elevated LFTs, ARF) CPK Urine antigen tests Serum legionella antibodies PCR
Cultures Sputum gram stain/culture; DFA sputum Blood cultures
LEGIONELLA: TMTS Fluoroquinolones
Levaquin Avelox
Macrolides Zithromax
Doxycycline Bactrim Rifampin
Extended course Initial IV therapy
CHLAMYDIA Chlamydia 3 sp (pneumoniae, psittaci, trachomatis) Gram negative obligate intracellular organisms (parasites) Unique organisms Community acquired Chlaymydia pneumoniae
Common Respiratory transmission (person to person) Pneumonia
Chlaymdia psittaci Rare Ornithosis Respiratory transmission (infected birds to humans) Pneumonia/Viral illness
CHLAMYDIA PNEUMONIA Clinical symptoms Incubation period: 1-4 weeks
Acute/subacute illness Self limited URI/bronchitis Fever Constitutional symptoms Cough Chest pain/sob Pharyngitis Sinusitis
Rales/Rhonchi/Wheezing
CHLAYMDIA PSITACCI Risk Factors—Contact with birds Clinical symptoms (incubation 5-30 days)
Acute viral illness/flu like symptoms Fever Relative bradycardia Constitutional symptoms Chest pain/sob Multi-system Neuro symptoms—HA, altered mental status HSM (elevated LFTs) Rash—Horder spots, EM, EN
Rales/Rhonchi/Wheezing/Clear lungs
CHLAMYDIA: DIAGNOSTICS Chlamydia pneumonia
CXR Cultures Serologic tests
Chlamydia psitacci CXR Cultures Serologic tests
CHLAMYDIA: TMTS Chlamydia pneumoniae
Doxycycline/Tetracycline Macrolides (Zithromax, Clarithromycin, E-mycin) Quinolones (Avelox, Levaquin)
Chlamydia psitacci Doxycycline/Tetracycline Macrolides (Zithromax, E-mycin)
VIRAL PNEUMONIAS More common in pediatric population and elderly Up to 15% of all CAP cases Mild>>>>Severe Influenza A & B RSV Adenoviruses Parainfluenza SARS Avian flu Varicella CMV Herpes virus Hanta virus
ANTIBIOTICS Outpatient/Inpatient/ICU
Remember coverage for CAP
Mycoplasma—Macrolide, Doxy Legionella—Quinolone, Macrolide Chlaymydia pneumonia—Doxy, Macrolide Chlaymida psitacci—Doxy, Macrolide Viral pneumonias
Supportive care Influenza—Tamiflu, think Staph coverage
HIV & PNEUMONIA Most common infectious process in HIV + patients Broaden differential diagnosis CD4 count & viral load important for specific organisms
and prognosis CAP most common Other
PCP TB MAC Histoplasmosis/Coccidiomycosis Viral pneumonias
PCP Pneumocystis carinii >> Pneumocystis jiroveci Unicellular fungus Various morphology--cysts Pre-HIV—few cases Most common opportunistic infection in HIV patients
Common cause of death in HIV patients; mortality ~ 15% Decreased incidence with prophylaxis and antiretroviral
treatment Transmission—human to human; airborne Pneumocystis is widespread
Symptomatic disease occurs in immunosuppressed populations
PCP: CLINICAL SYMPTOMS Symptoms
SOB (exertional) Cough Fevers Constitutional symptoms Chest pain
Signs Tachypnea/Fever/Tachycardia Rales/RhonchiWheezing Cachexia Lymphadenopathy Cyanosis
PCP: DIAGNOSTICS Labs
CBC, SMA-7 LDH ABG
Imaging CXR—variable
Normal>>Diffuse b/l infiltrates>>Perihilar infiltrates>>PTX CT scan
Diffuse b/l infiltrates>>Ground glass appearance>>Cysts
Sputum culture BAL Complication—PTX!
PCP: TMT Supportive treatments
Oxygen Noninvasive/Invasive ventilation
Antibiotics (14-21 days or until clinical response achieved) Bactrim IV Pentamadine IV or aerosolized Atovaquone po
Other therapies Steroids—Hypoxemia, PaO2 < 70, Severe disease
Prophylaxis
PCP: COMPLICATIONS Hypoxemic respiratory failure
ARDS
PTX
Risk for other opportunistic infections
SUMMARY Atypical pneumonias
Mycoplasma
Legionella
Chlamydia
Viral pneumonias
HIV & pneumonia PCP